1. United Nations General Assembly. Transforming OurWorld:
The 2030 Agenda for Ustainable Development. Geneva:
UnitedNations; 2015.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, AdairRohani H,
et al. A comparative risk assessment of burden of disease and
injury attributable to 67 risk factors and risk factor clusters in 21
regions, 1990–2010: A systematic analysis for the Global Burden
of Disease Study 2010. Lancet 2012;380:2224‑60.
3. Moradi M, Aghaei A, Najafi F, Mahboubi M, Ataee M, Lotfi B, et al.
Epidemiology of drug abuse and drug dependence in individuals
visiting drug abuse treatment centers in Kermanshah province in
2013. J Biol Todays World 2015;4:156‑64.
4. Rehm J, Mathers C, Popova S, Thavorncharoensap M,
Teerawattananon Y, Patra J. Global burden of disease and injury
and economic cost attributable to alcohol use and alcohol‑use
disorders. Lancet 2009;373:2223‑33.
5. Divsalar K, Mahmoodi M, Nakhaee N. Economic appraisal of
urine opiates screening test: A study in kerman, iran. Addict
Health 2011;3:79‑84.
6. Amin‑Esmaeili M, Rahimi‑Movaghar A, Sharifi V, Hajebi A,
Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug
use disorders in Iran: Prevalence, correlates, comorbidity and
service utilization results from the Iranian Mental Health Survey.
Addiction 2016;111:1836‑47.
7. Abbasi MM, Ansari M, Shahesmaeili A, Qaraie A. Lead serum
levels in opium‐dependent individuals. Addict Health 2009;1:106.
8. Aghaee‑Afshar M, Khazaeli P, Behnam B, Rezazadehkermani M,
Ashraf‑Ganjooei N. Presence of lead in opium. Arch Iran Med
2008;11:553‑4.
9. Jalili M, Azizkhani R. Lead toxicity resulting from chronic
ingestion of opium. West J Emerg Med 2009;10:244‑6.
10. Mokri A. Brief overview of the status of drug abuse in Iran. Arch
Iran Med 2002;5:184‑90.
11. Salehi H, Sayadi AR, Tashakori M, Yazdandoost R, Soltanpoor N,
Sadeghi H, et al. Comparison of serum lead level in oral opium
addicts with healthy control group. Arch Iran Med 2009;12:555‑8.
12. Nakhaee N, Ziaaddini H, Karimzadeh A. Epidemiologic study on
drug abuse among first and second grade high school students
in Kerman. Addict Health 2009;1:31‑6.
13. Hamzeh B, Moradi Z, Najafi F, Moradinazar M. Pattern of
Substance Abuse and Prevalence of Risk Factors of HIV and
Hepatitis among Addicted Women in Western Iran. Int J Prev
Med 2019;10:58.
14. Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A,
Noroozi A. Lead poisoning outbreak among opium users in the
Islamic Republic of Iran, 2016–2017. Bulletin of the World Health
Organization. 2018;96:165.
15. Asadikaram G, Akbari H, Vakili S, Asiabanha M, Shahrokhi N,
Savardashtaki A. The effect of opium addiction on thyroid and
sex hormones in diabetic and non‑diabeticmale and female rats.
Acta Endocrinol (Buchar) 2018;14:466‑72.
16. Menati W, Valizadeh R, Menati R, Niazi M, Nazarzadeh M,
Bidel Z. Determination of opium abuse prevalence in Iranian
young people: A systematic review and meta‑analysis. J Subst
Use 2017;22:3‑10.
17. Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A,
Khoshnia M, et al. Causes of premature death and their associated
risk factors in the Golestan Cohort Study, Iran. BMJ Open
2018;8:e021479.
18. Carew AM, Comiskey C. Treatmentfor opioid use and outcomes in
older adults: A systematicliterature review. Drug Alcohol Depend
2018;182:48‑57.
19. Asadikaram G, Akbari H, Vakili S, Asiabanha M, Shahrokhi N,
Savardashtaki A. The effect of oppium addiction on thyroid and
sex hormones in diabetic and non‑diabetic male and female rats.
Acta endocrinol (Buchar) 2018;14:466‑72.
20. Mousavi‑Mirzaei SM, Talebi A, Amirabadizadeh A, Nakhaee S,
Azarkar G, Mehrpour O. Increasing the risk of stroke by opium
addiction. J Stroke Cerebrovasc Dis 2019;28:1930‑5.
21. Martínez MA, Ballesteros S. Opium poisoning in modern times.
An overview. Forensic Sci Int 2019;302:109848.
22. Merikangas KR, Dierker LC, Szatmari P. Psychopathology
among offspring of parents with substance abuse and/or
anxiety disorders: A high‑risk study. J Child Psychol Psychiatry
1998;39:711‑20.
23. Sadock BJ, Sadock VA. Kaplan and Sadock’s comprehensive
textbook of psychiatry. In: Cohen MA, Gorman GM, editors.
Comprehensive Textbook of AIDS Psychiatry. New York: Oxford
University Press; 2007. p. 1139.
24. Moss HB, Baron DA, Hardie TL, Vanyukov MM. Preadolescent
children of substance‑dependent fathers with antisocial
personality disorder: Psychiatric disorders and problem
behaviors. Am J Addict 2001;10:269‑78.
25. Weissman MM, McAvay G, Goldstein RB, Nunes EV, Verdeli H,
Wickramaratne PJ. Risk/protective factors among addicted
mothers’ offspring: A replication study. Am J Drug Alcohol Abuse
1999;25:661‑79.
26. Strang J, Bearn J, Farrell M, Finch E, Gossop M, Griffiths P,
et al. Route of drug use and its implications for drug effect, risk
of dependence and health consequences. Drug Alcohol Rev
1998;17:197‑211.
27. Froutan H, Zadeh AK, Kalani M, Andrabi Y. Lead toxicity:
A probable cause of abdominal pain in drug abusers. Med J Islam
Repub Iran 2011;25:16‑20.
28. Shiri R, Ansari M, Ranta M, Falah‑Hassani K. Lead poisoning and
recurrent abdominal pain. Ind Health 2007;45:494‑6.
29. Fatemi R, Jafarzadeh F, Moosavi S, Afshar Amin F. Acute lead
poisoning in an opium user: A case report. Gastroenterol Hepatol
Bed Bench 2008;1:99‑101.
30. Verheij J, Voortman J, van Nieuwkerk CM, Jarbandhan SV,
Mulder CJ, Bloemena E. Hepatic morphopathologic findings of
lead poisoning in a drug addict: A case report. J Gastrointestin
Liver Dis 2009;18:225‑7.
31. Alinejad S, Aaseth J, Abdollahi M, Hassanian‑Moghaddam H,
Mehrpour O. Clinical Aspects of opium adulterated with lead in
Iran: A review. Basic Clin Pharmacol Toxicol 2018;122:56‑64.
32. Zamani N, Hassanian‑Moghaddam H. Notes from the Field: Lead
Contamination of Opium ‑ Iran, 2016. MMWR Morb Mortal Wkly
Rep 2018;66:1408‑9.
33. Aghajeri T, Hasani H. The impact of king Tahmasb I’s Ban
on Opium consumption in the first period of the Safavi
Government (996‑907 AH). J Islamic Iran History 2017;27:37‑64.
34. Aghili Khorasani MH. Makhzan‑ Al‑ Adviyeh. Tehran: Tehran
University of Medical Sciences; 2013.
35. Moosavyzadeh A, Ghaffari F, Mosavat SH, Zargaran A, Mokri A,
Faghihzadeh S, et al. The medieval Persian manuscript of
Afyunieh: The first individual treatise on the opium and addiction
in history. J Integr Med 2018;16:77‑83.
36. Cheraghi Niroumand M, Abbasian A, Khodadoust M, Yousefi
M, Khalili M . The Status of Traditional and Complementary
Medicine in the World. 1th ed. Tehran: Al-Maii Publishing; 2016.
37. Burton A, Falkenberg T, Smith M, Zhang Q, Zhang X. WHO
traditional medicine strategy: 2014-2023 [Online]. 2013. Available
from: URL: https://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/ Burton. [Last accessed on
2020 Apr 15].
38. Pal S, Shukla Y. Herbal medicine: Current status and the future.
Asian Pac J Cancer Prev 2003;4:281‑8.
39. Kamali M, Tajadini H, Seifadini R, Mehrabani M, Jahani Y,
Kamali H. The Effectiveness of Combination of Viola odorata
L., Rosa damascena Mill. and Coriandrum sativum L. on Quality
of Life of Patients with Migraine Headaches: A Randomized,
Double Blinded, Placebo-Controlled Clinical Trial. Traditional
and Integrative Medicine. 2019.
40. Kamali M, Seifadini R, Kamali H, Mehrabani M, Jahani Y,
Tajadini H. Efficacy of combination of Viola odorata, Rosa damascena
and Coriandrum sativum in prevention of migraine attacks:
A randomized, double blind, placebo‑controlled clinical trial.
Electron Physician 2018;10:6430‑8.
41. Tajadini HC, Kamali M. From Nessian to Alzheimer’s: A review
of the perspectives of traditional Persian medicine. J Tradit Med
Islam Iran 2019;10:137‑45.
42. Choopani R, Kamali M. From “Nesian” to Alzheimer's disease: A
review of the traditional Persian medicine perspectives. Journal
of Islamic and Iranian Traditional Medicine. 2019;10:137-46.
43. Shirazi EM. Resale Afiooniye. 1th ed. Tehran: Almaee Publishing;
2009.
44. Aghili Khorasani MH. Qarabadin‑ E‑ Kabir. Tehran: Safire Erdehal
Publisher; 2015.
45. Hakim Mohammad Momen Tonekaboni M. Tohfe‑Al‑Momenin.
Tehran: Traditional Medicine Research Center and Shahid
Beheshti University of Medical Sciences; 2007.
46. Alchaghmini M. Qanoonche Fi Teb. Correction and Translation:
Nazem E. 2nd ed. Tehran: Almaee Publishing; 2012.
47. Al Hokama R, Naseri MA. Iran University of Medical Sciences,
Institute of Medical History Studies, Islamic and Complementary
Medicine Publishing.
48. Jurjani E. Zakhire Kharazmshahi. Tehran: Bonyade Farhang‑e
Iran; 1976.
49. Avicenna. The Cannon of Medicine. Tehran, Iran: Sorush
Publication; 1983.
50. Naseri M, Rezaeizadeh H, Choopani R, Anoushirvani M. A review
of the generalities of traditional Iranian medicine. Tehran, Iran:
Traditional Iranian Medicine Publications; 2012.
51. Mosleh G, Badr P. Qairooti (Cerate or Cera Beeswax Salve) in
traditional Iranian pharmacy. Iran J Med Sci 2016;41:S8.
52. Aghili Khorasani MH. Kholase‑ Al‑ Hekma. Qom: Institute
of Medical Studies and History of Islamic Medicine and
Complementary; 2007.
53. Sadeghpoor O. Fundamentals of Traditional Farmacy ‑ Book One.
2nd ed. Tehran: Al‑Mai Publications; 2016. p. 48‑40.
54. Persian Wikipedia. Available from: https://fa.wikipedia.
o r g / w i k i / % D 8 % A F % D 8 % A 7 % D 9 % 8 6 % D 9 % 8 7 _
(%DB%8C%DA%A9%D8%A7. [Last accessed on 2020 Apr 16].
55. Heravi A. Abniye an Haqayegh Al Adviye. Tehran: Tehran
University of Medical Sciences Publishing; 1995.
56. Moein Dictionary, 8th Edition. In: Shahidi SJ, editor. Moeen
Dictionary. Tehran: Amir Kabir Publishing Institute; 1972.
57. Anooshiravani M. Five Medical Treatises. 1st ed. Tehran, Iran:
Chogan Publication in Collaboration with the Faculty of Persian
Medicine, Tehran University of Medical Sciences; 2013. p. 68‑7.
58. Emami A, Fasihi S, Mehregan I. PDR. Tehran, Iran: Andishe
Publication; 2010.
59. Zargari A. Medicinal Herbs. 7th ed. Tehran: Tehran University
Press Institute; 1390.
60. KamaliM, Tajadini H, MehrabaniM, MoghadariM. Consequences
of opioid abuse and their treatments in Persian medicine:
A review study. Addict Health 2020;12:46‑57.
61. Moghadari M, Tajadini H, Setayesh M, Kamali M. Alcohol
Abuse, Consequences, and Treatments from the Perspective
of Traditional Iranian Medicine: A Review Study. Addiction &
Health. 2019;11:192.
62. Chashti H. Exir‑ e‑ Azam. Tehran: Thran University of Medical
Sciences, Institute for Islamic and Complementary Medicine; 2008.
63. Chashti H. Qarabadin e Azam va Akmal. 2nd ed. Tehran: Iran
University of Medical Sciences Publishing; 2004.
64. Pourmand A, Khedir Al‑Tiae T, Mazer‑Amirshahi M. Perspective
on lead toxicity, a comparison between the United States and Iran.
Daru 2012;20:70.
65. Amiri M, Amini R. A comparison of blood‐lead level (BLL) in
opium‐dependant addicts with healthy control group using the
graphite furnace/atomic absorption spectroscopy (GF‐AAS)
followed by chemometric analysis. Iran Red Crescent Med J
2012;14:488‑91.
66. Lebni JY, Toghroli R, Abbas J, NeJhaddadgar N, Salahshoor MR,
Mansourian M, et al. A study of internet addiction and its effects
on mental health: A study based on Iranian University Students.
J Educ Health Promot 2020;9:205.
67. Alavi SS, Jannatifard F, Maracy MR, Alaghemandan H, Setare M.
Comparison of national and personal identity between person
with internet addiction disorder and normal internet users. J Educ
Health Promot 2014;3:42.